If you are using the famous drug Ranitidine as antacid, You need to be very careful! The Drug Controller of India has reportedly issued a public health warning on the anti-acidity drug Ranitidine.

The Drug Controller of India has issued a public health warning on the anti-acidity drug Ranitidine. In a statement issued by the drug controller, it has been reportedly said that there are many chemicals found in the drug Ranitidine, which can cause a risk of cancer.

It is worth mentioning that the drug Ranitidine is not only used as antacid, but also in the treatment of many other diseases like intestinal ulcers, gastroesophageal reflux disease, esophagitis. This drug is available in different formulations in the market in tablet and injection form. Some pharma companies sell both these drugs in 180 types.

Warning issued by Drug Controller of India

According to the reports, Directorate General of Health Services Drug Controller, VG Somani has issued a warning to all the states of the country regarding the issue related to Ranitidine medicine. States have been ordered to take action on this.

Notably, the probability that it might cause cancer was first detected by the FDA of America and an alert was issued in this regard.

Doctors advised not to prescribe this medicine

Companies producing this medicine in India have been asked to stop production of this medicine with immediate effect. According to the instructions of the Drug Controller, doctors have been advised not to prescribe this medicine to patients.

The Quality, Safety and Capacity-Quality Control Organization of India, The Central Drugs Standard Control Organization, has reportedly referred the matter related to Ranitidine to an expert committee. This committee will investigate the Ranitidine drug issue.

1 out 3 Indian consumes Ranitidine

Ranitidine the most popular acidity drug…widely available as Rantac, Aciloc, Zinetac, Histac, etc.  has been found to contain Cancer causing Chemical (NDMA). As per an estimate every 1 out 3 Indian consumes Ranitidine in form of Rantac, Zinetac, Aciloc, Histac, etc. All the developed countries have already initiated the action with sales completely stopped in Canada, Singapore and Baharain.

A global leader in sales of Ranitidine has alredy stopped sales following the US-Food and Drug Administration. India Government seems to have acted slowly in this regard.

TAGS: Ranitidine tablet, antacid tablet, ranitidine cancer